Professional Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $32.5M | Buy |
64,819
+5,804
| +10% | +$2.79M | 3.89% | 4 |
|
|
2026
Q1 | $29M | Buy |
59,015
+7,995
| +16% | +$4.34M | 4% | 6 |
|
|
2025
Q4 | $29.6M | Sell |
51,020
-8,491
| -14% | -$4.8M | 3.83% | 5 |
|
|
2025
Q3 | $28.9M | Buy |
59,511
+23,369
| +65% | +$10.9M | 3.76% | 5 |
|
|
2025
Q2 | $14.7M | Sell |
36,142
-17,056
| -32% | -$7.13M | 1.99% | 29 |
|
|
2025
Q1 | $26.5M | Sell |
53,198
-2,770
| -5% | -$1.5M | 3.71% | 8 |
|
|
2024
Q4 | $29.1M | Buy |
55,968
+20,479
| +58% | +$11.3M | 4.02% | 4 |
|
|
2024
Q3 | $22M | Sell |
35,489
-1,101
| -3% | -$652K | 2.88% | 18 |
|
|
2024
Q2 | $20.2M | Sell |
36,590
-153
| -0.4% | -$87.7K | 2.76% | 22 |
|
|
2024
Q1 | $21.4M | Sell |
36,743
-3,073
| -8% | -$1.72M | 2.9% | 18 |
|
|
2023
Q4 | $21.1M | Buy |
39,816
+2,768
| +7% | +$1.34M | 3.02% | 11 |
|
|
2023
Q3 | $18.8M | Buy |
37,048
+915
| +3% | +$488K | 3.08% | 17 |
|
|
2023
Q2 | $18.9M | Buy |
36,133
+35,123
| +3,478% | +$19M | 2.86% | 22 |
|
|
2023
Q1 | $582K | Buy |
1,010
+10
| +1% | +$5.64K | 0.09% | 46 |
|
|
2022
Q4 | $551K | Hold |
1,000
| – | – | 0.09% | 49 |
|
|
2022
Q3 | $507K | Sell |
1,000
-72
| -7% | -$40.3K | 0.09% | 45 |
|
|
2022
Q2 | $582K | Hold |
1,072
| – | – | 0.1% | 44 |
|
|
2022
Q1 | $633K | Hold |
1,072
| – | – | 0.09% | 44 |
|
|
2021
Q4 | $715K | Hold |
1,072
| – | – | 0.1% | 41 |
|
|
2021
Q3 | $612K | Hold |
1,072
| – | – | 0.09% | 41 |
|
|
2021
Q2 | $541K | Buy |
1,072
+72
| +7% | +$34K | 0.08% | 44 |
|
|
2021
Q1 | $456K | Hold |
1,000
| – | – | 0.07% | 46 |
|
|
2020
Q4 | $466K | Hold |
1,000
| – | – | 0.07% | 44 |
|
|
2020
Q3 | $442K | Hold |
1,000
| – | – | 0.08% | 44 |
|
|
2020
Q2 | $362K | Hold |
1,000
| – | – | 0.07% | 46 |
|
|
2020
Q1 | $284K | Sell |
1,000
-45
| -4% | -$14.2K | 0.07% | 51 |
|
|
2019
Q4 | $339K | Buy |
1,045
+45
| +5% | +$13.6K | 0.06% | 56 |
|
|
2019
Q3 | $291K | Hold |
1,000
| – | – | 0.06% | 57 |
|
|
2019
Q2 | $294K | Hold |
1,000
| – | – | 0.06% | 54 |
|
|
2019
Q1 | $274K | Hold |
1,000
| – | – | 0.06% | 56 |
|
|
2018
Q4 | $224K | Hold |
1,000
| – | – | 0.05% | 62 |
|
|
2018
Q3 | $244K | Sell |
1,000
-25
| -2% | -$5.75K | 0.05% | 62 |
|
|
2018
Q2 | $212K | Buy |
1,025
+25
| +3% | +$5.31K | 0.04% | 62 |
|
|
2018
Q1 | $206K | Buy |
+1,000
| New | +$210K | 0.04% | 62 |
|
|
2014
Q1 | – | Sell |
-94,816
| Closed | -$10.6M | – | 52 |
|
|
2013
Q4 | $10.6M | Sell |
94,816
-28,783
| -23% | -$2.86M | 2.74% | 22 |
|
|
2013
Q3 | $11.4M | Sell |
123,599
-1,108
| -0.9% | -$100K | 3.21% | 16 |
|
|
2013
Q2 | $10.6M | Buy |
+124,707
| New | +$10.4M | 3.15% | 17 |
|
Other funds holding TMO
LT
CF
SP
DLA
PL
HPC
Professional Advisory Services's TMO Position: Q2 2026 in Review
Professional Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 9.8% in Q2 2026, buying an estimated $2.79M and bringing the position to 64,819 shares worth $32.5M. The position accounts for 3.89% of the portfolio, ranked #4.
Professional Advisory Services first reported a position in TMO in Q2 2013 and has held it in 37 quarters since. 500 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Professional Advisory Services held 64,819 shares of Thermo Fisher Scientific worth $32.5M as of Q2 2026.
- Professional Advisory Services bought 5,804 Thermo Fisher Scientific shares in Q2 2026, an estimated $2.79M.
- Thermo Fisher Scientific made up 3.89% of Professional Advisory Services's portfolio in Q2 2026, its #4 holding.
- Professional Advisory Services first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 37 quarters since.
- 500 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Professional Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.